Denali Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $144.5M | $1.37B | $175.0M |
| FY2025 | $131.1M | $1.14B | $205.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $144.5M | $1.37B | $175.0M |
| FY2025 | $131.1M | $1.14B | $205.3M |